Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery
Hepatocellular carcinoma (HCC) is the sixth most common form of cancer worldwide. Although surgical treatments have an acceptable cure rate, tumor recurrence is still a challenging issue. In this meta-analysis, we investigated whether statins prevent HCC recurrence following liver surgery.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
21 January 2022
|
| In: |
BMC cancer
Year: 2022, Jahrgang: 22, Pages: 1-9 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/s12885-022-09192-1 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12885-022-09192-1 |
| Verfasserangaben: | Elias Khajeh, Arash Dooghaie Moghadam, Pegah Eslami, Sadeq Ali-Hasan-Al-Saegh, Ali Ramouz, Saeed Shafiei, Omid Ghamarnejad, Sepehr Abbasi Dezfouli, Christian Rupp, Christoph Springfeld, Carlos Carvalho, Pascal Probst, Seyed Mostafa Mousavizadeh and Arianeb Mehrabi |
| Zusammenfassung: | Hepatocellular carcinoma (HCC) is the sixth most common form of cancer worldwide. Although surgical treatments have an acceptable cure rate, tumor recurrence is still a challenging issue. In this meta-analysis, we investigated whether statins prevent HCC recurrence following liver surgery. |
|---|---|
| Beschreibung: | Gesehen am 11.08.2022 |
| Beschreibung: | Online Resource |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/s12885-022-09192-1 |